LENSAR, Inc. Files Proxy Materials
Ticker: LNSR · Form: DEFA14A · Filed: Jun 25, 2025 · CIK: 1320350
| Field | Detail |
|---|---|
| Company | Lensar, Inc. (LNSR) |
| Form Type | DEFA14A |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory
TL;DR
LENSAR filed proxy docs, no fee. Standard procedure.
AI Summary
LENSAR, Inc. filed a Definitive Additional Materials proxy statement on June 25, 2025. The filing indicates no fee was required for this submission. The company, specializing in surgical and medical instruments, is based in Orlando, Florida.
Why It Matters
This filing is a routine regulatory submission for LENSAR, Inc., providing updated information to shareholders and the SEC regarding company matters.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement, not indicating any immediate financial or operational risks.
Key Players & Entities
- LENSAR, Inc. (company) — Registrant
- 2800 DISCOVERY DRIVE (location) — Business Address
- ORLANDO (location) — City
- FL (location) — State
- 32826 (location) — ZIP Code
FAQ
What type of filing is this?
This is a Definitive Additional Materials filing (DEFA14A) for LENSAR, Inc.
When was this filing submitted?
The filing was submitted on June 25, 2025.
What is LENSAR, Inc.'s primary business?
LENSAR, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.
Where is LENSAR, Inc. located?
LENSAR, Inc. is located in Orlando, Florida.
Was there a filing fee associated with this document?
No fee was required for this filing.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 25, 2025 regarding LENSAR, Inc. (LNSR).